Nautilus Biotechnology
Latest round
- Series B
Last raised
- Apr 2020
Total raised
- $76M
Investors
- 8
About Nautilus Biotechnology
Based in California, US, and founded in 2016, Nautilus Biotechnology Inc. is a biotechnology company that develops a therapeutic development that focuses on controlling protein present in the cell, tissue, and organism. The company's CEO is Sujal Patel. The company is composed of protein chemists, chip designers, molecular biologists, data scientists, material scientists, biophysicists, optical engineers, microfluidics engineers, bioinformaticists, and software engineers that help in developing Proteomics. Proteomics is a substance that controls proteins that is present in the cell, tissue, or organism. It offers therapeutic development, diagnostics, and basic science research to develop FDA-approved drugs for protein enhancement. The company's revenue is generated by providing biomedical research by delivering a single-molecule proteomics platform for analyzing and quantifying the human proteome.
Who invested in Nautilus Biotechnology
8 investors across 1 round
See all investors in Nautilus Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Apr 8, 2020
Amount
$76M
Investors
Questions about Nautilus Biotechnology
Who invested in Nautilus Biotechnology?
Nautilus Biotechnology has 8 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nautilus Biotechnology raised?
Nautilus Biotechnology has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Nautilus Biotechnology last raise money?
Nautilus Biotechnology's most recent round on record is a Series B, in Apr 2020.
What does Nautilus Biotechnology do?
Based in California, US, and founded in 2016, Nautilus Biotechnology Inc.
Where is Nautilus Biotechnology headquartered?
Nautilus Biotechnology is headquartered in San Carlos, US.
Which VCs invest in companies like Nautilus Biotechnology?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Nautilus Biotechnology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Nautilus Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.